FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiation.
Yan J, Zhao Q, Gabrusiewicz K, Kong LY, Xia X, Wang J, Ott M, Xu J, Davis RE, Huo L, Rao G, Sun SC, Watowich SS, Heimberger AB, Li S.
Yan J, et al. Among authors: zhao q.
Nat Commun. 2019 Jan 25;10(1):448. doi: 10.1038/s41467-018-08271-x.
Nat Commun. 2019.
PMID: 30683885
Free PMC article.